1.
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs
by DUXIN SUN
Pharmaceutical research, 2002, Vol.19 (10), p.1400-1416

2.
Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models
by LUNDQUIST, Stefan
Pharmaceutical research, 2002, Vol.19 (7), p.976-981

3.
Transfer of dopamine in the olfactory pathway following nasal administration in mice
by DAHLIN, M
Pharmaceutical research, 2000, Vol.17 (6), p.737-742

4.
Drug equilibration across the blood-brain barrier : Pharmacokinetic considerations based on the microdialysis method
by HAMMARLUND-UDENAES, M
Pharmaceutical research, 1997, Vol.14 (2), p.128-134

5.
Enzymatic degradation of epichlorohydrin crosslinked starch microspheres by α-amylase
by HAMDI, G
Pharmaceutical research, 1999, Vol.16 (6), p.867-875

6.
Splenic trapping of nanoparticles : Complementary approaches for in situ studies
by DEMOY, M
Pharmaceutical research, 1997, Vol.14 (4), p.463-468

7.
The measurement of small quantities of amorphous material--should we be considering the rigid amorphous fraction?
by Craig, D Q
Pharmaceutical research, 2001-08, Vol.18 (8), p.1081-1082

8.
Regional rectal perfusion : a new in vivo approach to study rectal drug absorption in man
by LENNARNÄS, H
Pharmaceutical research, 1995, Vol.12 (3), p.426-432

9.
A pharmacokinetic model of intravenously administered hyaluronan in sheep
by LEBEL, L
Pharmaceutical research, 1989, Vol.6 (8), p.677-682

10.
Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
by DYER, A. M
Pharmaceutical research, 2002, Vol.19 (7), p.998-1008

11.
A novel phase inversion-based process for the preparation of lipid nanocarriers
by HEURTAULT, Béatrice
Pharmaceutical research, 2002, Vol.19 (6), p.875-880

12.
Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs
by RASENACK, Norbert
Pharmaceutical research, 2002, Vol.19 (12), p.1894-1900

13.
Chitosan and its use as a pharmaceutical excipient
by ILLUM, L
Pharmaceutical research, 1998, Vol.15 (9), p.1326-1331

14.
Fundamental effects of particle morphology on lung delivery: Predictions of stokes' law and the particular relevance to dry powder inhaler formulation and development
by CROWDER, Timothy M
Pharmaceutical research, 2002, Vol.19 (3), p.239-245

15.
A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations
by SIEPMANN, Juergen
Pharmaceutical research, 2002, Vol.19 (12), p.1885-1893

16.
Protein instability in poly(lactic-co-glycolic acid) microparticles
by DE WEERT, Marco Van
Pharmaceutical research, 2000, Vol.17 (10), p.1159-1167

17.
Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor
by QUINTANA, Antonio
Pharmaceutical research, 2002, Vol.19 (9), p.1310-1316

18.
Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules
by GUPTA, Manish K
Pharmaceutical research, 2002, Vol.19 (11), p.1663-1672

19.
Recent advances in vaccine adjuvants
by SINGH, Manmohan
Pharmaceutical research, 2002, Vol.19 (6), p.715-728

20.
What is the true solubility advantage for amorphous pharmaceuticals?
by HANCOCK, B. C
Pharmaceutical research, 2000, Vol.17 (4), p.397-404
